广州白云山医药集团股份有限公司于2026年1月2日发布2025年12月股份变动月报表，报告期截止日为2025年12月31日。公告显示，截止当月末，公司股本结构保持稳定，未出现新增发行、股份购回或注销等变动情形。
报告显示，公司H股（代码：00874）于本月底发行数量为219,900,000股，A股（代码：600332）于本月底发行数量为1,405,890,949股，均与上月底保持一致。同时，本月底法定注册股本总额仍为人民币1,625,790,949元。公司在当月无期权、权证或其他股权激励计划变动，也未进行任何购回或注销股份的操作。
公司并在公告中确认，所有相关股份发行及交易均严格遵守香港联交所《上市规则》和其他适用法律法规的要求。本次月报由公司董事程宁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.